Morgan Stanley’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $396 | Hold |
|
|||||
|
2023
Q2 | $406 | Buy |
|
|||||
|
2023
Q1 | $69 | Sell |
|
|||||
|
2022
Q4 | $63 | Buy |
|
|||||
|
2022
Q3 | $0 | Hold |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $0 | Buy |
|
|||||
|
2021
Q4 | $0 | Sell |
|
|||||
|
2021
Q3 | $5K | Sell |
|
|||||
|
2021
Q2 | $21K | Sell |
|
|||||
|
2021
Q1 | $38K | Buy |
|
|||||
|
2020
Q4 | $22K | Buy |
|
|||||
|
2020
Q3 | $21K | Hold |
|
|||||
|
2020
Q2 | $31K | Hold |
|
|||||
|
2020
Q1 | $6K | Sell |
|
|||||
|
2019
Q4 | $10K | Hold |
|
|||||
|
2019
Q3 | $5K | Hold |
|
|||||
|
2019
Q2 | $5K | Sell |
|
|||||
|
2019
Q1 | $22K | Buy |
|
|||||
|
2018
Q4 | $16K | Hold |
|
|||||
|
2018
Q3 | $36K | Hold |
|
|||||
|
2018
Q2 | $36K | Sell |
|
|||||
|
2018
Q1 | $60K | Buy |
|
|||||
|
2017
Q4 | $59K | Sell |
|
|||||
|
2017
Q3 | $75K | Buy |
|
|||||
|
2017
Q2 | $90K | Buy |
|
|||||
|
2017
Q1 | $102K | Buy |
|
|||||
|
2016
Q4 | $111K | Buy |
|
|||||
|
2016
Q3 | $154K | Sell |
|
|||||
|
2016
Q2 | $92K | Sell |
|
|||||
|
2016
Q1 | $191K | Sell |
|
|||||
|
2015
Q4 | $314K | Buy |
|
|||||
|
2015
Q3 | $476K | Buy |
|
|||||
|
2015
Q2 | $298K | Sell |
|
|||||
|
2015
Q1 | $305K | Sell |
|
|||||
|
2014
Q4 | $475K | Sell |
|
|||||
|
2014
Q3 | $345K | Buy |
|
|||||
|
2014
Q2 | $333K | Buy |
|
|||||
|
2014
Q1 | $412K | Buy |
|
|||||
|
2013
Q4 | $396K | Sell |
|
|||||
|
2013
Q3 | $523K | Sell |
|
|||||
|
2013
Q2 | $619K | Buy |
|